Cargando…
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
BACKGROUND: The neutrophil lymphocyte ratio (NLR) has prognostic value in patients with a variety of cancers. Many chemotherapeutic trial databases hold information on white cell and neutrophil counts only. The aim of the present study was to compare the prognostic value of the NLR with a derived sc...
Autores principales: | Proctor, M J, McMillan, D C, Morrison, D S, Fletcher, C D, Horgan, P G, Clarke, S J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419948/ https://www.ncbi.nlm.nih.gov/pubmed/22828611 http://dx.doi.org/10.1038/bjc.2012.292 |
Ejemplares similares
-
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011) -
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival
por: Cummings, M, et al.
Publicado: (2015) -
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
por: Chua, W, et al.
Publicado: (2011) -
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2010) -
Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
por: Chen, Z-Y, et al.
Publicado: (2015)